| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| J Hietala, E MacDonald, M Scheini. Presynaptic dopamine receptors in the pithed rat: characterization with apomorphine and comparison with central dopamine autoreceptors. Acta pharmacologica et toxicologica. vol 59. issue 4. 1987-02-10. PMID:3799208. |
the sensitivity of peripheral presynaptic dopamine receptors was then studied in the cardiovascular system of rats treated subchronically with haloperidol (2 mg/kg, twice daily intraperitoneally for 10 days). |
1987-02-10 |
2023-08-11 |
rat |
| D D Rasmussen, J H Liu, W H Swartz, V S Tueros, S S Ye. Human fetal hypothalamic GnRH neurosecretion: dopaminergic regulation in vitro. Clinical endocrinology. vol 25. issue 2. 1987-02-05. PMID:3539416. |
an in-vitro perifusion system was used to investigate gnrh release from fetal (21-23 weeks gestation) human hypothalami in response to dopamine (da) and the da receptor antagonist haloperidol. |
1987-02-05 |
2023-08-11 |
human |
| J Logan, A P Wolf, C Y Shiue, J S Fowle. Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers. Journal of neurochemistry. vol 48. issue 1. 1987-01-29. PMID:2432176. |
in this study we investigate the kinetics of the 3,4-dihydroxyphenylethylamine (dopamine) receptor-ligand binding using pet data from a series of experiments in the baboon with the 18f-labeled drugs spiperone, haloperidol, and benperidol. |
1987-01-29 |
2023-08-11 |
Not clear |
| S N Baksi, M J Hughes, H K Strahlendor. Adrenal catecholamine concentration after chronic treatment with bromocriptine and haloperidol. The Journal of pharmacy and pharmacology. vol 38. issue 10. 1987-01-23. PMID:2879003. |
haloperidol treatment, on the other hand, had no significant effect on dopamine and a biphasic effect on adrenaline content. |
1987-01-23 |
2023-08-11 |
rat |
| R J Kemppainen, J L Sarti. In vivo evidence for dopaminergic regulation of the canine pituitary intermediate lobe. Acta endocrinologica. vol 113. issue 4. 1987-01-22. PMID:3024439. |
in order to examine regulation of pituitary intermediate lobe secretion, plasma immunoreactive (i)acth, cortisol, and alpha-msh responses to iv bolus injections of crf, quipazine maleate (serotonin agonist), isoproterenol (beta-adrenergic agonist) or haloperidol (dopamine antagonist) were determined in conscious, unrestrained dogs. |
1987-01-22 |
2023-08-11 |
Not clear |
| R J Kemppainen, J L Sarti. In vivo evidence for dopaminergic regulation of the canine pituitary intermediate lobe. Acta endocrinologica. vol 113. issue 4. 1987-01-22. PMID:3024439. |
however, infusion of bromocriptine mesylate (dopamine agonist) in combination with dexamethasone pre-treatment reduced the plasma i alpha-msh response to haloperidol. |
1987-01-22 |
2023-08-11 |
Not clear |
| N Lindefors, T Sharp, U Ungersted. Effects of subchronic haloperidol and sulpiride on regional brain dopamine metabolism in the rat. European journal of pharmacology. vol 129. issue 3. 1987-01-22. PMID:3780852. |
effects of subchronic haloperidol and sulpiride on regional brain dopamine metabolism in the rat. |
1987-01-22 |
2023-08-11 |
rat |
| L H Schneider, J Gibbs, G P Smit. D-2 selective receptor antagonists suppress sucrose sham feeding in the rat. Brain research bulletin. vol 17. issue 4. 1987-01-20. PMID:2946362. |
to determine if this effect was due to the blockade of the d-2 subclass of dopamine receptors, we investigated the effects of the selective d-2 receptor antagonists sultopride and (-)-sulpiride as well as the effects of the preferential d-2 receptor antagonists, haloperidol and pimozide, on sucrose sham feeding. |
1987-01-20 |
2023-08-11 |
rat |
| F Drago, U Scapagnin. Hormonal modulation of central dopaminergic transmission. Journal of neural transmission. Supplementum. vol 22. 1987-01-20. PMID:3023550. |
ablation of hypophysis prevents the supersensitivity of central dopamine receptors induced by chronic treatment with the dopamine receptor antagonist, haloperidol. |
1987-01-20 |
2023-08-11 |
rat |
| V Fuchs, H Coper, S Strauss, H Rommelspache. Diazepam attenuates the antagonism of haloperidol against apomorphine-induced stereotypic behavior after subchronic but not acute treatment in rats. Naunyn-Schmiedeberg's archives of pharmacology. vol 334. issue 2. 1987-01-15. PMID:3024028. |
binding studies on dopamine (d1), 5-hydroxytryptamine (5-ht2) and benzodiazepine receptors revealed that modification of the apomorphine-induced stereotypies by the combined treatment with haloperidol and diazepam cannot be explained by interactions of the drugs at the level of the d1, 5-ht2 or benzodiazepine-receptors. |
1987-01-15 |
2023-08-11 |
rat |
| A P Signorella, W C Hyme. Characterization of a substance in rat serum which modulates prolactin release in vitro. Molecular and cellular endocrinology. vol 48. issue 1. 1987-01-14. PMID:3781096. |
the inability of the dopamine antagonist, haloperidol, to block the inhibitory effect of rat serum indicated that the material does not exert its effect through the dopamine receptor. |
1987-01-14 |
2023-08-11 |
rat |
| A Ettenberg, C H Cam. Haloperidol induces a partial reinforcement extinction effect in rats: implications for a dopamine involvement in food reward. Pharmacology, biochemistry, and behavior. vol 25. issue 4. 1987-01-13. PMID:3786340. |
haloperidol induces a partial reinforcement extinction effect in rats: implications for a dopamine involvement in food reward. |
1987-01-13 |
2023-08-11 |
rat |
| P T Loosen, J C Garbutt, A Tiperma. The TRH test during dopamine receptor blockade in depressed patients. Psychoneuroendocrinology. vol 11. issue 3. 1987-01-12. PMID:3097692. |
in an evaluation of the possible role of dopamine on trh test results, 21 depressed patients were given trh before and after one week of treatment with a low dose of haloperidol. |
1987-01-12 |
2023-08-11 |
Not clear |
| P C Waldmeier, L Maître, P A Baumann, K Hauser, S Bischoff, H Bittiger, R Paion. Ifoxetine, a compound with atypical effects on serotonin uptake. European journal of pharmacology. vol 130. issue 1-2. 1987-01-06. PMID:2877890. |
ifoxetine (cgp 15210 g; (+/-)-bis-[cis-3-hydroxy-4-(2,3-dimethyl-phenoxy)]-piperidine sulfate) prevented the depletion of serotonin (5-ht) induced by h 75/12 and p-chloromethamphetamine in the rat brain, and that caused by endogenously released dopamine after the combined administration of haloperidol and amfonelic acid in the rat striatum. |
1987-01-06 |
2023-08-11 |
human |
| M Steinhausen, S Weis, J Fleming, R Dussel, N Parek. Responses of in vivo renal microvessels to dopamine. Kidney international. vol 30. issue 3. 1986-12-31. PMID:3023735. |
after pretreatment with haloperidol, dopamine (1 x 10(-6) to 1 x 10(-4) m) did not dilate any pre- or postglomerular vascular segment, but the tendency for pre- and postglomerular constrictions with higher dopamine concentrations were not abolished. |
1986-12-31 |
2023-08-11 |
Not clear |
| K A Cunningham, P M Callahan, J B Appe. Discriminative stimulus properties of the serotonin agonist MK 212. Psychopharmacology. vol 90. issue 2. 1986-12-22. PMID:3097699. |
the 5-ht1/5-ht2 antagonists bc 105, metergoline, and methysergide completely blocked the mk 212 cue, while the selective 5-ht2 antagonists ketanserin and pirenperone, the dopamine antagonists haloperidol and spiperone, and the beta-noradrenergic antagonist propranolol were without effect. |
1986-12-22 |
2023-08-11 |
rat |
| P Poyet, B Gagne, F Labri. Characteristics of the beta-adrenergic stimulation of adenylate cyclase activity in rat ventral prostate and its modulation by androgens. The Prostate. vol 9. issue 3. 1986-12-03. PMID:3022260. |
the stimulatory effect exerted by high concentrations of dopamine (greater than 0.1 mm) is completely reversed by propranolol but not by haloperidol or sulpiride, thus indicating an action of dopamine mediated by the beta-adrenergic receptor. |
1986-12-03 |
2023-08-11 |
rat |
| J Yanai, C G Pick, C Iser-Strenge. Chronic treatment with haloperidol affect the response of the brain to pentobarbital. Neuropharmacology. vol 25. issue 8. 1986-11-24. PMID:2945998. |
treatment of mice with haloperidol increased the number of dopamine d2 receptors (bmax). |
1986-11-24 |
2023-08-11 |
mouse |
| K Kashihara, M Sato, Y Fujiwara, T Ogawa, K Fukuda, S Otsuk. Effects of intermittent and continuous haloperidol administration on the dopaminergic system in the rat brain. Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology. vol 6. issue 2. 1986-11-24. PMID:3022499. |
the effects of intermittent and continuous treatment with haloperidol (hpd) on dopamine turnover in the rat brain were studied. |
1986-11-24 |
2023-08-11 |
rat |
| M D Schechte. Dopaminergic mediation of a behavioral effect of l-cathinone. Pharmacology, biochemistry, and behavior. vol 25. issue 2. 1986-11-21. PMID:3020593. |
pretreatment with 0.2 mg/kg of the specific dopamine blocking drug haloperidol increased this ed50 to 0.47 mg/kg and significantly decreased discriminative performance when co-administered with either 0.15, 0.3, or 0.6 mg/kg l-cathinone. |
1986-11-21 |
2023-08-11 |
rat |